GlassScriptPhysician profile
Trung Ha
NPI 1780936971
$5,960.46
in general payments reported to CMS, 2019-2025
15 companies · $735 in 2025
The $735 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,580 · 2020: $143 · 2021: $69.82 · 2022: $3,080 · 2023: $252 · 2024: $101 · 2025: $735.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $649 · Travel and Lodging: $438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $648.81 |
| Travel and Lodging | $438.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,098.40 | 2019-2025 | Eterna, Proclaim, Penta |
| Boston Scientific Corporation | $986.91 | 2019 | |
| Pylant Medical | $626.33 | 2025 | |
| Orthofix Medical, INC. | $298.81 | 2022 | |
| Cerapedics INC. | $140.84 | 2022 | |
| Vertiflex, INC. | $125.60 | 2019 | |
| Medtronic USA, INC. | $114.58 | 2019 | |
| Pfizer INC. | $100.82 | 2019 | |
| Medline Industries LP | $92.62 | 2025 | |
| Gilead Sciences, INC. | $86.31 | 2019 | |
| Spinesmith Holdings, LLC | $84.61 | 2019 | |
| Electronic Waveform Lab, INC. | $69.82 | 2021 | |
| Medtronic, INC. | $65.83 | 2022 | |
| Saluda Medical Americas, INC. | $55.28 | 2023 | Evoke Scs |
| Allergan, INC. | $13.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trung Ha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.